文献速递创伤骨科关节外科骨肿瘤

肿瘤性股骨颈骨折:半髋与全髋置换无差异

No Difference Between Hemiarthroplasty and Total Hip Arthroplasty in the Treatment of Pathologic Femoral Neck Fractures.
PubMed 文献 · J Arthroplasty · 2021-07-29

这项多中心回顾性队列研究比较了2005至2018年间半髋置换与全髋置换治疗肿瘤性股骨颈骨折的效果,共纳入半髋116例、全髋48例。两组在再手术率、90天死亡率、围手术期并发症及功能状态方面均无显著差异。研究表明两种术式均为可选方案。

要点

  • 半髋与全髋置换治疗肿瘤性股骨颈骨折再手术率无差异(5.2% vs 4.2%,P=1.00)。
  • 围手术期并发症、功能状态及住院指标在两组间均无显著差异。

核心结论

  • 半髋置换与全髋置换均为肿瘤性股骨颈骨折的可行治疗选择,在再手术、并发症、围手术期90天死亡率及功能评分方面无差异。

研究设计与样本

  • 多中心回顾性队列研究,纳入2005至2018年接受半髋或全髋置换治疗的肿瘤性股骨颈骨折患者,半髋组116例,全髋组48例。

主要发现

  • 半髋组与全髋组再手术率分别为5.2%与4.2%,差异无统计学意义(P=1.00)。
  • 两组在估计失血量、输血率、住院时间、出院去向、假体周围感染、假体周围骨折及术前术后ECOG体能状态方面均无差异。

关键数值与推荐

  • 再手术率:半髋5.2% vs 全髋4.2%,P=1.00。
  • 证据等级:Level III。

临床怎么用

  • 对于肿瘤性股骨颈骨折,半髋置换与全髋置换均可作为治疗选项,术式选择可基于个体化考量。

局限性

  • 回顾性研究设计,样本量有限(半髋116例、全髋48例),证据等级为Level III。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hemiarthroplasty (HA) and total hip arthroplasty (THA) have been widely discussed as treatment options for displaced osteoporotic femoral neck fractures. Pathologic femoral neck fractures from primary or metastatic tumors are comparatively rare and poorly investigated. The purpose of this study was to compare outcomes, complications, and perioperative survival for HA and THA in the treatment of pathologic femoral neck fractures of neoplastic etiology. METHODS: A multicenter retrospective cohort study identified patients with pathologic femoral neck fractures treated with HA or THA from 2005 to 2018. Demographics, American Society of Anesthesiologists classification, Charlson comorbidity index, Dorr classification, histopathologic diagnosis, and surgical data were compared. The primary outcome was reoperation. Secondary outcomes included 90-day mortality, estimated blood loss, length of stay, periprosthetic fracture, periprosthetic joint infection, and Eastern Cooperative Oncology Group performance status. RESULTS: There were 116 patients with HA and 48 patients with THA, with no differences between groups with regard to American Society of Anesthesiologists classification, Charlson comorbidity index, or Dorr classification. There were no differences between HA and THA in the primary outcome of reoperation (5.2% vs 4.2%, P = 1.00) or secondary outcomes of perioperative 90-day overall mortality (30.2% vs 25.0%, P = .51), estimated blood loss, transfusion rates, length of stay, discharge location, periprosthetic joint infection, periprosthetic fracture, or preoperative or postoperative Eastern Cooperative Oncology Group performance status. CONCLUSIONS: Both HA and THA are viable options for the treatment of patients with pathologic femoral neck fractures and demonstrated no differences in reoperations, complications, perioperative 90-day mortality, or functional outcome scores. LEVEL OF EVIDENCE: Level III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hayden BL, Varady NH, Abdeen A, et al. No Difference Between Hemiarthroplasty and Total Hip Arthroplasty in the Treatment of Pathologic Femoral Neck Fractures. J Arthroplasty. 2021. PMID: 34419316. doi:10.1016/j.arth.2021.06.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。